Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Rhythm Pharmaceuticals (RYTM) Other Non Operating Income (2021 - 2025)

Historic Other Non Operating Income for Rhythm Pharmaceuticals (RYTM) over the last 5 years, with Q3 2025 value amounting to $274000.0.

  • Rhythm Pharmaceuticals' Other Non Operating Income fell 7481.62% to $274000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year decrease of 8910.67%. This contributed to the annual value of $8.9 million for FY2024, which is 458421.05% up from last year.
  • Latest data reveals that Rhythm Pharmaceuticals reported Other Non Operating Income of $274000.0 as of Q3 2025, which was down 7481.62% from $1.6 million recorded in Q2 2025.
  • Rhythm Pharmaceuticals' 5-year Other Non Operating Income high stood at $100.0 million for Q1 2021, and its period low was -$644000.0 during Q1 2025.
  • Its 5-year average for Other Non Operating Income is $7.4 million, with a median of -$17000.0 in 2023.
  • As far as peak fluctuations go, Rhythm Pharmaceuticals' Other Non Operating Income skyrocketed by 5245294.12% in 2024, and later tumbled by 22290.08% in 2025.
  • Rhythm Pharmaceuticals' Other Non Operating Income (Quarter) stood at $100.0 million in 2021, then crashed by 100.42% to -$420000.0 in 2022, then soared by 233.1% to $559000.0 in 2023, then surged by 94.63% to $1.1 million in 2024, then tumbled by 74.82% to $274000.0 in 2025.
  • Its Other Non Operating Income stands at $274000.0 for Q3 2025, versus $1.6 million for Q2 2025 and -$644000.0 for Q1 2025.